
Julius Toltesi (Unsplash) / Unsplash License
Clinical Trials/November 3, 2026/3 min read
Recruiting Type 1 diabetes trials watch: what changed in the current registry feed
A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.
clinical trialsClinicalTrials.govT1Dtrial matching
What this is and is not
This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.
A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?
Recruiting records to inspect
- A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes — RECRUITING, PHASE1, PHASE2. Interventions: Anti-thymocyte globulin (ATG), verapamil extended-release capsule, Adalimumab. Locations: Los Angeles, California, United States | San Francisco, California, United States | Ne...Source
- SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes — RECRUITING, PHASE2. Interventions: High Dose SAB-142, Low Dose SAB-142, Placebo. Locations: San Francisco, California, United States | San Jose, California, United States | Aurora, Colorado, United States. This is a Pha...Source
- Think-Find-Solve Activities for Insulin Self-Management in Type 1 Diabetes — RECRUITING, NA. Interventions: Insulin Self-Management Know-Find-Solve Activity Book, Routine education. Locations: Istanbul, Turkey (Türkiye). Children with type 1 diabetes require lifelong insulin therapy. However, im...Source
- A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults — RECRUITING, PHASE3. Interventions: Baricitinib, Placebo. Locations: Santa Barbara, California, United States | Tallahassee, Florida, United States | Iowa City, Iowa, United States. The purpose of this study is to find o...Source
- Immune Function and the Progression to T1D — RECRUITING. Interventions: blood draw. Locations: Gainesville, Florida, United States | Columbus, Ohio, United States | Houston, Texas, United States. To elucidate the mechanisms by which type 1 diabetes-associated gene...Source
- Restoration of Hypoglycemia Awareness With Metoclopramide — RECRUITING, PHASE2. Interventions: Metoclopramide, Placebo. Locations: Lexington, Kentucky, United States | Salt Lake City, Utah, United States. Metoclopramide is a drug approved by the FDA for gastroesophageal reflux a...Source
- A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers — RECRUITING, PHASE4. Interventions: XWRAP. Locations: Hollywood, Florida, United States. A multicenter, prospective, controlled clinical trial evaluating the efficacy of a single layer placental-based allograft and stand...Source
- Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression — RECRUITING, NA. Interventions: Unified protocol for cognitive behavioral therapy (UP-CBT), Continuous Glucose Monitoring (CGM). Locations: Boston, Massachusetts, United States | The Bronx, New York, United States. This...Source
Questions before contacting a study
- Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
- What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
- Can the family discuss the official record with their endocrinology team before sharing additional personal health details?
This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.